2025 Private Equity Compensation Report
Annually, our team conducts a comprehensive survey to reveal insights into the changing landscape of private equity and venture capital compensation.
The Private Equity Compensation Report, which covers Venture Capital Compensation in detail as well, has grown to become the most comprehensive benchmark for private equity and venture capital compensation practices in the industry. The Report represents a compensation benchmark resource that is comprehensive, reliable and affordable.
Download the Report Instantly for only $995
What We Offer
- Base vs. Bonus – broken out by level of earnings
- Average Compensation by Title
- Carried Interest (“Carry”) Participation by Title
- Carry Participation by Years of Work Experience
- Cash Compensation by Fund Size for most common titles
- Full table of Earnings by Title (mean and ranges)
- Hours Worked per Week
- Vacation Earned vs. Taken
- Upside Sharing
- Plus much more
Try before you buy
Get the Benchmarks
The Report addresses core compensation topics, much more than just cash compensation.
Get Paid What You're Worth
This report will give you what you need whether you are negotiating your own compensation package or setting benchmarks for your firm’s compensation policies.
Information = Power
This Report is up-to-date, comprehensive, reasonably priced, and guaranteed. Download your free copy now and you’ll be on your way to more successful compensation policies.
Download the report instantly
The Private Equity & VC Compensation Report
Independent. Comprehensive. Reliable.
Some of the participating firms over the years include:
• 3i | • EdgeStone Capital Partners |
• Actis | • Global Environment Fund |
• American Capital | • Highland Capital Partners |
• Babson Capital Management | • Hilco Consumer Capital |
• Bain Capital | • Kaiser Permanente Ventures |
• Barclays Capital | • Kayne Anderson |
• BlackRock | • North Atlantic Capital |
• Clairvest | • Qualcomm |
• CPP Investment Board | • RBS |
• Deutsche Bank | • Safeguard Scientifics |
• DuPont Capital Management | • SV Life Sciences |
• EDC Equity | • Time Warner Investments |